U
IDXX icon

UBS’s Idexx Laboratories IDXX Stock Holding History

UBS’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$12K Buy
+200
New +$12.6K ﹤0.01% 8627

Other funds holding IDXX

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's IDXX Position: Q3 2014 in Review

UBS reduced its Idexx Laboratories (IDXX) stake by 11% in Q3 2014, selling an estimated $358K and leaving 44,504 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

UBS first reported a position in IDXX in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.35M in Q2 2014. 319 funds tracked by Wall St. Rank hold IDXX as of Q3 2014.

  • UBS held 44,504 shares of Idexx Laboratories worth $2.62M as of Q3 2014.
  • UBS sold 5,670 Idexx Laboratories shares in Q3 2014, an estimated $358K.
  • Idexx Laboratories made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2648 holding.
  • UBS first reported a position in Idexx Laboratories in Q2 2013 and has held it in 6 quarters since.
  • UBS's Idexx Laboratories position peaked at $3.35M in Q2 2014.
  • 319 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.